- KYPROLIS® (carfilzomib) is indicated in combination with dexamethasone or with lenalidomide plus dexamethasone or with daratumumab and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy. ... Read More
Resources for DKd
Not an actual patient
Meet Diane, a 65-year-old active female
Hypothetical case study of a high-risk* patient with multiple myeloma at first relapse
Introducing the phase 3 CANDOR study (DKd vs Kd)
Learn more about the CANDOR study and how DKd may help your patients with relapsed multiple myeloma.
DKd = KYPROLIS®+Darzalex® (daratumumab) and dexamethasone; Kd = KYPROLIS®+dexamethasone.